Katerzia® (amlodipine benzoate) oral suspension
Approval Date: Jun 2023
For the treatment of hypertension and coronary artery disease
Inpefa™ (sotagliflozin) tablets
Approval Date: May 2023
Indicated to reduce the risk of cardiovascular death, hospitalization for heart failure, and urgent heart failure visit in adults with heart failure or type 2 diabetes
Byvalson™ (nebivolol and valsartan) tablets
Approval Date: Sep 2022
Indicated for the treatment of hypertension, to lower blood pressure
Edarbi® (azilsartan medoxomil) tablets
Approval Date: Jul 2022
Indicated for the treatment of hypertension to lower blood pressure
Norliqva® (amlodipine) oral solution
Approval Date: Feb 2022
A peppermint-flavored solution indicated for the treatment of hypertension and angina. Amlodipine is available as a generic in oral tablets.
Aspruzyo Sprinkle ™ (ranolazine) extended release granules
Approval Date: Feb 2022
Indicated for the treatment of chronic angina, a type of chest pain caused by reduced blood flow to the heart.